Navigation Links
Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
Date:9/14/2010

BARCELONA, Spain, Sept. 14 /PRNewswire/ -- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from the first two European hospitals to start clinical treatments using the new TrueBeam system – Zurich University Hospital in Switzerland and VU University Medical Center in Amsterdam, Netherlands - addressed an Emerging Technologies Symposium at the annual ESTRO conference here in Barcelona to give detailed accounts of early patient treatments.  

Professor Urs Luetolf of Zurich University Hospital said, "When we introduce new technology it is always interesting for our fellow radiation oncologists and radiation therapists to hear about clinical process improvements for treatment delivery and imaging which enables us to handle organ and tumor motion, but clinical medicine has one main goal – to add something for patient.

"We have treated more than 100 patients on the TrueBeam system since we introduced it six months ago and, although it's too early to assess outcomes, it's clear the system offers advantages in terms of the speed and precision of delivery," Prof. Luetolf added. "Cancer patients constantly seek a better cure and fewer side effects and they want to be treated using the latest and most advanced technology, and our experiences with this advanced system to date have been encouraging for patients as well as making the treatment process more straightforward for clinicians."

Professor Ben Slotman, head of radiation oncology at VU University Medical Center, outlined the results of patient treatments that commenced using the new TrueBeam system earlier this month, beginning with that of an 80-year-old lung cancer patient for whom surgery was deemed
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
2. First Patient Enrolled in CONNECT Clinical Trial
3. Reportlinker Adds Clinical Trials in China
4. Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
5. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
6. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
7. First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
8. Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials
11. Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... 21, 2010 ... ... var shortURL = ... so we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; ...
... Pharma L.P. announces the launch of its new pharmacy ... enforcement officials and loss prevention personnel can follow updates ... area and nationwide. The tweets provide safety and security ... protect customers and their businesses. Followers also receive notices ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10Twitter Provides New Way to Fight Pharmacy Crime 2
(Date:4/17/2014)... April 17, 2014 By discovering a new mechanism ... a stroke, researchers at UC Irvine and the Salk ... may limit or prevent stroke-induced brain damage. , A ... cause of death and primary reason for disability in ... a stroke and lets blood-borne material into the brain, ...
(Date:4/17/2014)... Cesar A. Arias, M.D., Ph.D., at The University of ... a new superbug that caused a bloodstream infection in ... 17 issue of The New England Journal of ... a class of highly-resistant bacteria known as methicillin-resistant ... cause of hospital and community-associated infections. The superbug has ...
(Date:4/17/2014)... than 40 years away from a food shortage that ... to a top scientist at the U.S. Agency for ... food production will be limited on a global scale ... Dr. Fred Davies, senior science advisor for the agency,s ... politically destabilizing by 2050 as energy issues are today.", ...
(Date:4/17/2014)... treatment that lost its status as the leading weapon ... lease of life, with new research indicating it simply ... revive the use of the cheap anti-malarial drug chloroquine ... the lives of more than half a million people ... causes malaria has developed resistance to chloroquine, but research ...
(Date:4/16/2014)... 2014) A team that includes scientists from the School ... at San Antonio, Johns Hopkins University and St. Mary,s University ... fungus to infect the body. , The fungal pathogen ... thrush, and is the most common fungal pathogen to infect ...
Breaking Medicine News(10 mins):Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:New MRSA superbug emerges in Brazil 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:Scientists find new way to fight malaria drug resistance 2
... its employees further strengthen community support by donating an ... giving campaign DUBLIN, Ohio, Feb. 18 The Cardinal ... $1.2 million to non-profit programs that seek to improve ... Cardinal Health has the highest concentration of employees. Over ...
... (Nasdaq: ALGN ) today announced that the Company ... against the Company on February 17, 2009 by ClearCorrect, Inc. ... of Texas. Align Technology became aware of the filing on ... copy of the Complaint.In the Complaint, assigned case # H-09-470 ...
... Who Use the OmniPod System to Manage their Diabetes , ... country,s top professional cross-country skiers, is competing on behalf of ... As a world-class athlete, Freeman intends to medal, but he ... Diabetes doesn,t keep Freeman from performing at the top ...
... from this trial supported entry into Company,s current ... -,BELLEVILLE, ON, Feb. 18 /PRNewswire-FirstCall/ - Bioniche Life ... biopharmaceutical company, today announced that The Journal of ... II clinical trial results for the Company,s proprietary ...
... Calif., Feb. 18 In a dramatic move ... direct care RN organizations, the,United American Nurses, California ... Association today announced,they are joining together to form ... The new organization will be called the ...
... of Hosted Microsoft Exchange, presents competitive risk-proof, out-of-the-box solution for resellers ... ... -- SherWeb , a global leader in hosted solutions ... last week. The newly implemented program provides IT solution providers with ...
Cached Medicine News:Health News:Cardinal Health Foundation Invests $1.2 Million in Local Non-Profit Programs That Improve Health in Key Employee Communities 2Health News:Cardinal Health Foundation Invests $1.2 Million in Local Non-Profit Programs That Improve Health in Key Employee Communities 3Health News:Cardinal Health Foundation Invests $1.2 Million in Local Non-Profit Programs That Improve Health in Key Employee Communities 4Health News:Cardinal Health Foundation Invests $1.2 Million in Local Non-Profit Programs That Improve Health in Key Employee Communities 5Health News:Align Technology Asserts ClearCorrect Complaint Is Without Merit 2Health News:Elite Skier Uses OmniPod(R) Insulin Management System at World Championships 2Health News:Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology 2Health News:Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology 3Health News:Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology 4Health News:SherWeb Launches Unique White Label Exchange Reseller Program 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: